Both Aphria (NYSE:APHA) and Constellation Brands (NYSE:STZ) are having a pretty good year so far in 2019. Both stocks are up over 20%. One key difference, though, is that Aphria’s success has stemmed from its cannabis operations, while Constellation’s gains have come despite its stake in Canopy Growth (NYSE:CGC) weighing on its performance.
Which of these two stocks is the better pick for long-term investors going forward? Here’s what you need to know about the opportunities for Aphria and Constellation Brands.
The case for Aphria
One of the first things that stands out when you examine Aphria is the company’s production capacity. Aphria can currently produce around 115,000 kilograms of cannabis on an annual basis in Canada, plus another 17,000 kilograms per year in its outdoor facility in Jamaica. Once the company’s Aphria Diamond greenhouse is approved, Aphria’s Canadian